Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma

Thorax

Volumn 51, Issue 12, 1996, Pages 1178-1184

  Evans, David J ^a   Barnes, Peter J ^b   Spaethe, Stephen M ^c   Van Alstyne, Eldwin L ^c   Mitchell, Malcolm I ^c   O'Connor, Brian J ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

asthma; leukotriene B4; myeloperoxidase; neutrophil

Indexed keywords

2 [2 PROPYL 3 [3 [2 ETHYL 4 (4 FLUOROPHENYL) 5 HYDROXYPHENOXY]PROPOXY]PHENOXY]BENZOIC ACID; ALLERGEN; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MYELOPEROXIDASE; PLACEBO; CYTOKINE; HISTAMINE; PEROXIDASE; PROSTAGLANDIN; THROMBOXANE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FORCED EXPIRATORY VOLUME; HUMAN; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; IMMUNOLOGY; INHALATION TEST; LUNG LAVAGE; MALE;

ADULT; ALLERGENS; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CROSS-OVER STUDIES; CYTOKINES; DOUBLE-BLIND METHOD; FORCED EXPIRATORY VOLUME; HISTAMINE; HUMANS; LEUKOTRIENE B4; MALE; PEROXIDASE; PROSTAGLANDINS; RECEPTORS, LEUKOTRIENE B4; THROMBOXANES;

EID: 0029658108     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.12.1178     Document Type: Article

References (29)

1. Barnes PJ, Chung KF, Page CP. Inflammatory mediators and asthma. Pharmacol Rev 1988;40:49-83.
2. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 1990;323:645-55.
3. Claesson HE, Odlander B, Jakobssen PJ. Leukotriene B, in the immune system. Int J Immunopharmaol 1992;14: 441-9.
4. 2 on bronchial responsiveness to histamine in normal subjects. Thorax 1989;44:491-5.
5. Martin TR, Pistorese BP, Chi EY, Goodman RB, Matthay MA. Effects of leukotriene B, in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein promeability. J Clin Invest 1989;84: 1609-19.
6. Durham SR. Late asthmatic responses. Respir Med 1990; 84:263-8.
7. De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-6.
8. Virchow JC Jr, Walker C, Hafner D, Korstik C, Werner P, Matthys H, et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995;151:960-8.
9. Metzger J, Zavala D, Richerson HB, Moseley P, Iwamota P, Monick M, et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis 1987;135:433-40.
10. Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE, et al. Sudden onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993;148: 713-9.
11. 1 in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989;84:19-26.
12. 1. Prostaglandins 1994;47:393-403.
13. 1 receptor antagonist. Biochem Pharmacol 1995;49:1683-90.
14. 1 receptor antagonist. J Invest Dermatol 1995;123:A74.
15. 1, a potent chemokinetic and aggregating substance released from polymorphonudear leukocytes. Nature 1980;286:264-5.
16. Broide DH, Lotz M, Cuomo AJ, Federman EG, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-67.
17. Smith HR, Larsen GL, Cherniack RM, Wenzel SH, Voelkel NF, Bethel RA. Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increases in airway responsiveness. J Allergy Clin Immunol 1992;89:1076-84.
18. Boschetto P, Mapp CE, Picotti G, Fahhri LM. Neutrophils and asthma. Eur Respir J 1989;6:456-9S.
19. 1-induced airway hyperresponsiveness in dogs. J Appl Physiol 1985;59:1941-6.
20. Holtzman MJ, Fabbri LM, O'Byrne PM, Gold BD, Aizawa H, Walters EH, et al. Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis 1983;127:686-90.
21. Marsh WR, Irvin CG, Murphy KR, Behrens BL, Larsen GL. Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model. Am Rev Respir Dis 1985;131:875-9.
22. Hutson PA, Church MK, Clay TP, Miller P, Holgate ST. Early and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea pigs. Am Rev Respir Dis 1988;137:548-57.
23. Lam S, Le Riche J, Phillips D, Chan-Yeung M. Cellular and protein changes in bronchial lavage fluid following late asthmatic reactions in patients red cedar asthma. J Allergy Clin Immunol 1987;80:44-50.
24. 1 antagonist U-75302 on antigen-induced bronchopulmonary eosinophilia in sensitized guinea pigs. Am Res Respir Dis 1989;140:1712-6.
25. Barnes PJ. Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med 1994;150:S42-9.
26. O'Byrne PM. Prostaglandins and thromboxane. In: Barnes PJ, Rodger IW, Thomson NS, eds. Asthma. Basic mechanisms and clinical management. 2nd edn. San Diego: Academic Press, 1992;14:225-34.
27. 2, on allergen-induced asthma. Am Rev Respir Dis 1993;148:87-90.
28. Stelzer J, Bigby BG, Stulbarg M, Holtzmann MJ, Nadel JA, Ueki IF. Ozone-induced changes in bronchial reactivity to methacholine and airway inflammation in humans. J Apl Physiol 1986;60:1321-6.
29. Fabbri LM, Boschetto P, Zocca H, Milani G, Pivirotto F, Plebani M, et al. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rer Rapir Dis 1987;136:36-42.